Novo Nordisk CEO to exit role
Current market conditions in the pharmaceutical industry have driven the…
Current market conditions in the pharmaceutical industry have driven the change to its executive leadership team, according to Novo Nordisk.
List view / Grid view
Current market conditions in the pharmaceutical industry have driven the…
Current market conditions in the pharmaceutical industry have driven the change to its executive leadership team, according to Novo Nordisk.
As part of its acquisition of Catalent, Novo Holdings plans…
As part of its acquisition of Catalent, Novo Holdings plans to sell three Catalent fill-finish sites, supporting the growth of the European and US manufacturing capacity.